165 related articles for article (PubMed ID: 1483475)
1. Molecular analysis of the protein-protein interaction between the E9 immunity protein and colicin E9.
Wallis R; Moore GR; Kleanthous C; James R
Eur J Biochem; 1992 Dec; 210(3):923-30. PubMed ID: 1483475
[TBL] [Abstract][Full Text] [Related]
2. Dual recognition and the role of specificity-determining residues in colicin E9 DNase-immunity protein interactions.
Li W; Hamill SJ; Hemmings AM; Moore GR; James R; Kleanthous C
Biochemistry; 1998 Aug; 37(34):11771-9. PubMed ID: 9718299
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 2. Cognate and noncognate interactions that span the millimolar to femtomolar affinity range.
Wallis R; Leung KY; Pommer AJ; Videler H; Moore GR; James R; Kleanthous C
Biochemistry; 1995 Oct; 34(42):13751-9. PubMed ID: 7577967
[TBL] [Abstract][Full Text] [Related]
4. Protein-protein interaction specificity of Im9 for the endonuclease toxin colicin E9 defined by homologue-scanning mutagenesis.
Li W; Dennis CA; Moore GR; James R; Kleanthous C
J Biol Chem; 1997 Aug; 272(35):22253-8. PubMed ID: 9268373
[TBL] [Abstract][Full Text] [Related]
5. Identification of residues in the putative TolA box which are essential for the toxicity of the endonuclease toxin colicin E9.
-Schneider CG; Penfold CN; Moore GR; Kleanthous C; James R
Microbiology (Reading); 1997 Sep; 143 ( Pt 9)():2931-2938. PubMed ID: 9308177
[TBL] [Abstract][Full Text] [Related]
6. Highly discriminating protein-protein interaction specificities in the context of a conserved binding energy hotspot.
Li W; Keeble AH; Giffard C; James R; Moore GR; Kleanthous C
J Mol Biol; 2004 Mar; 337(3):743-59. PubMed ID: 15019791
[TBL] [Abstract][Full Text] [Related]
7. Specificity in protein-protein recognition: conserved Im9 residues are the major determinants of stability in the colicin E9 DNase-Im9 complex.
Wallis R; Leung KY; Osborne MJ; James R; Moore GR; Kleanthous C
Biochemistry; 1998 Jan; 37(2):476-85. PubMed ID: 9425068
[TBL] [Abstract][Full Text] [Related]
8. Identification of critical residues in the colicin E9 DNase binding region of the Im9 protein.
Osborne MJ; Wallis R; Leung KY; Williams G; Lian LY; James R; Kleanthous C; Moore GR
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):823-31. PubMed ID: 9169618
[TBL] [Abstract][Full Text] [Related]
9. Experimental and computational analyses of the energetic basis for dual recognition of immunity proteins by colicin endonucleases.
Keeble AH; Joachimiak LA; Maté MJ; Meenan N; Kirkpatrick N; Baker D; Kleanthous C
J Mol Biol; 2008 Jun; 379(4):745-59. PubMed ID: 18471830
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the specificity of the interaction between colicin E9 and its immunity protein by site-directed mutagenesis.
Curtis MD; James R
Mol Microbiol; 1991 Nov; 5(11):2727-33. PubMed ID: 1779762
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis.
Garinot-Schneider C; Pommer AJ; Moore GR; Kleanthous C; James R
J Mol Biol; 1996 Aug; 260(5):731-42. PubMed ID: 8709151
[TBL] [Abstract][Full Text] [Related]
12. Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes.
Kühlmann UC; Pommer AJ; Moore GR; James R; Kleanthous C
J Mol Biol; 2000 Sep; 301(5):1163-78. PubMed ID: 10966813
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro characterization of overproduced colicin E9 immunity protein.
Wallis R; Reilly A; Rowe A; Moore GR; James R; Kleanthous C
Eur J Biochem; 1992 Jul; 207(2):687-95. PubMed ID: 1633820
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional solution structure and 13C nuclear magnetic resonance assignments of the colicin E9 immunity protein Im9.
Osborne MJ; Breeze AL; Lian LY; Reilly A; James R; Kleanthous C; Moore GR
Biochemistry; 1996 Jul; 35(29):9505-12. PubMed ID: 8755730
[TBL] [Abstract][Full Text] [Related]
15. Tandem overproduction and characterisation of the nuclease domain of colicin E9 and its cognate inhibitor protein Im9.
Wallis R; Reilly A; Barnes K; Abell C; Campbell DG; Moore GR; James R; Kleanthous C
Eur J Biochem; 1994 Mar; 220(2):447-54. PubMed ID: 8125102
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of a mobile protein-binding epitope in the translocation domain of colicin E9.
Macdonald CJ; Tozawa K; Collins ES; Penfold CN; James R; Kleanthous C; Clayden NJ; Moore GR
J Biomol NMR; 2004 Sep; 30(1):81-96. PubMed ID: 15452437
[TBL] [Abstract][Full Text] [Related]
17. Calorimetric dissection of colicin DNase--immunity protein complex specificity.
Keeble AH; Kirkpatrick N; Shimizu S; Kleanthous C
Biochemistry; 2006 Mar; 45(10):3243-54. PubMed ID: 16519519
[TBL] [Abstract][Full Text] [Related]
18. Flexibility in the receptor-binding domain of the enzymatic colicin E9 is required for toxicity against Escherichia coli cells.
Penfold CN; Healy B; Housden NG; Boetzel R; Vankemmelbeke M; Moore GR; Kleanthous C; James R
J Bacteriol; 2004 Jul; 186(14):4520-7. PubMed ID: 15231784
[TBL] [Abstract][Full Text] [Related]
19. Structural dynamics of the membrane translocation domain of colicin E9 and its interaction with TolB.
Collins ES; Whittaker SB; Tozawa K; MacDonald C; Boetzel R; Penfold CN; Reilly A; Clayden NJ; Osborne MJ; Hemmings AM; Kleanthous C; James R; Moore GR
J Mol Biol; 2002 May; 318(3):787-804. PubMed ID: 12054823
[TBL] [Abstract][Full Text] [Related]
20. A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cells.
Penfold CN; Garinot-Schneider C; Hemmings AM; Moore GR; Kleanthous C; James R
Mol Microbiol; 2000 Nov; 38(3):639-49. PubMed ID: 11069686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
